Microfluidics Fight Covid (CoronaVirus Disease)
Enabling detective, preventive, and curative technologies for COVID
Recognizing the danger of genome modification and reorganization
Submit Your Input
| The FDA-approved Drug Ivermectin inhibits the replication of SARS-CoV-2 in vitro, reported on AntiViral Research (2020). |
| Moderna's Coronavirus Vaccine and Pittsburgh CoronaVirus Vaccine (PittCoVacc) |
| A very old drug is coming back to the fore. The successful testing of hydroxychloroquine and azithromycin for use against the coronavirus in France's second city Marseille on March 16 created high expectations amid this surging epidemic - especially in light of Donald Trump's announcement on Thursday that the US Food and Drug Administration has approved its use for this purpose. |
| Phylogenetic network analysis of SARS-CoV-2 genomes, reported on PNAS (2020). |
| Genomic epidemiology of hCoV-19 (Enabled by data from GISAID), showing 848 of 848 genomes sampled between Dec 2019 and Mar 2020 and comprising 5 recencys, 5 locations, 5 divisions, 5 countries, 5 hosts, 5 regions, 5 authors, 5 originating labs and 5 submitting labs. |
| Identifying SARS-CoV-2 related coronaviruses in Malayan pangolins on Nature (2020). |
| The proximal origin of SARS-CoV-2 on Nature Medicine (2020). |
| Lost On December 2019 is an artical mentioned some critical dates for causing the outbreak of COVID-19. | The 2019-20 coronavirus outbreak is an ongoing global outbreak of coronavirus disease 2019 that has been declared a Public Health Emergency of International Concern. |
| Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), previously known by the provisional name 2019 novel coronavirus (2019-nCoV), is a positive-sense single-stranded RNA virus. |